Truist Boosts Colgate-Palmolive (NYSE:CL) Price Target to $85.00

Colgate-Palmolive (NYSE:CL) had its price target lifted by Truist from $80.00 to $85.00 in a research note published on Monday, The Fly reports.

A number of other research analysts have also recently commented on CL. TheStreet upgraded Colgate-Palmolive from a c+ rating to a b+ rating in a research note on Friday, July 31st. Morgan Stanley upped their price target on Colgate-Palmolive from $78.00 to $80.00 and gave the stock an equal weight rating in a research note on Monday, August 3rd. Deutsche Bank Aktiengesellschaft increased their price objective on Colgate-Palmolive from $75.00 to $78.00 and gave the company a hold rating in a research note on Monday, August 3rd. Finally, Royal Bank of Canada reiterated a buy rating and issued a $88.00 price objective on shares of Colgate-Palmolive in a research note on Thursday, July 30th. Three analysts have rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the company’s stock. Colgate-Palmolive presently has a consensus rating of Hold and an average price target of $76.08.

Shares of Colgate-Palmolive stock opened at $76.67 on Monday. The firm has a market capitalization of $65.74 billion, a price-to-earnings ratio of 25.64, a PEG ratio of 4.54 and a beta of 0.59. Colgate-Palmolive has a fifty-two week low of $58.49 and a fifty-two week high of $80.99. The company has a debt-to-equity ratio of 9.40, a quick ratio of 0.59 and a current ratio of 0.92. The stock has a 50 day moving average of $77.86 and a 200 day moving average of $74.60.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, July 31st. The company reported $0.74 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.05. The company had revenue of $3.90 billion during the quarter, compared to analyst estimates of $3.78 billion. Colgate-Palmolive had a return on equity of 559.34% and a net margin of 16.13%. The firm’s revenue for the quarter was up .8% compared to the same quarter last year. During the same period in the prior year, the business posted $0.72 earnings per share. Analysts forecast that Colgate-Palmolive will post 2.96 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Shareholders of record on Friday, October 23rd will be paid a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a yield of 2.30%. The ex-dividend date is Thursday, October 22nd. Colgate-Palmolive’s dividend payout ratio is presently 62.19%.

In other Colgate-Palmolive news, insider Sally Massey sold 387 shares of the firm’s stock in a transaction dated Monday, September 28th. The stock was sold at an average price of $77.30, for a total transaction of $29,915.10. Following the transaction, the insider now owns 4,856 shares of the company’s stock, valued at $375,368.80. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, VP Philip G. Shotts sold 401 shares of the firm’s stock in a transaction dated Monday, September 28th. The stock was sold at an average price of $77.29, for a total value of $30,993.29. Following the transaction, the vice president now directly owns 41,263 shares in the company, valued at approximately $3,189,217.27. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 256,994 shares of company stock worth $19,678,851. 0.78% of the stock is owned by insiders.

Several hedge funds have recently modified their holdings of the business. Fundamentun LLC grew its holdings in shares of Colgate-Palmolive by 4.5% during the third quarter. Fundamentun LLC now owns 8,334 shares of the company’s stock worth $643,000 after purchasing an additional 357 shares during the last quarter. Stratos Wealth Partners LTD. grew its holdings in shares of Colgate-Palmolive by 3.3% during the third quarter. Stratos Wealth Partners LTD. now owns 12,984 shares of the company’s stock worth $1,002,000 after buying an additional 417 shares during the last quarter. DekaBank Deutsche Girozentrale grew its holdings in shares of Colgate-Palmolive by 176.4% during the third quarter. DekaBank Deutsche Girozentrale now owns 710,436 shares of the company’s stock worth $53,608,000 after buying an additional 453,363 shares during the last quarter. Railway Pension Investments Ltd grew its holdings in shares of Colgate-Palmolive by 3.8% during the third quarter. Railway Pension Investments Ltd now owns 744,712 shares of the company’s stock worth $57,455,000 after buying an additional 27,200 shares during the last quarter. Finally, CAPROCK Group Inc. grew its holdings in shares of Colgate-Palmolive by 4.2% during the third quarter. CAPROCK Group Inc. now owns 7,452 shares of the company’s stock worth $575,000 after buying an additional 302 shares during the last quarter. 76.74% of the stock is currently owned by institutional investors.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment products include toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items.

Further Reading: What causes a yield curve to invert?

The Fly

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.